ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q1 2021 Results - Earnings Call Transcript
Allogene Therapeutics, Inc. (ALLO) Q1 2021 Earnings Conference Call May 05, 2021, 05:00 PM ET Company Participants Christine Cassiano - CCO David Chang - President and CEO Rafael Amado - EVP-Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Salveen Richter - Goldman Sachs Marc Frahm - Cowen & Company Kelly Shi - Jefferies Michael Schmidt - Guggenheim John Newman - Canaccord Cory Kasimov - J.P. Morgan Luca Issi - RBC Capital Mark Breidenbach - Oppenheimer Ben Burnett - Stifel Dane Leone - Raymond James Randy Benjamin - JMP Securities Raju Prasad - William Blair Asthika Goonewardene - Truist Securities Presentation Operator Good afternoon, ladies and gentlemen, thank you for standing by, and welcome to the Allogene Therapeutics First Quarter 2021 Conference Call. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded. I would
For further details see:
Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2021 Results - Earnings Call Transcript